What the OptumRx Litigation Means to Industry

What the OptumRx Litigation Means to Industry

We have received a lot of questions over the past few weeks on how the lawsuit is progressing and what it will mean for the industry. Although we do not have any definitive answers yet (a court decision could come as early as June), we do have some highlights from our...
Developments Regarding the OptumRx Lawsuit

Developments Regarding the OptumRx Lawsuit

A new development in the NABP / OptumRx lawsuit over OptumRx’s VAWD Accreditation requirement has lead to the extension of the de facto “injunction”  from OptumRx’s VAWD requirement for the wholesale plaintiffs of that suit. Case Development A review of the...
NABP / Optum Rx VAWD Lawsuit

NABP / Optum Rx VAWD Lawsuit

Three generic drug wholesalers, Oak Drugs (“Oak”), Matrix Distributors (“Matrix”), and Primed Pharmaceuticals (“Primed”) are challenging Optum Rx’s VAWD Requirement. The plaintiffs have recently received encouraging news from the U.S District Court for the District of...